In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Predictors of Hearing Loss after Gamma Knife Radiosurgery for Vestibular Schwannoma

    Final Number:
    1419

    Authors:
    Jeffrey T. Jacob M.D.; Matthew L. Carlson; Terry K. Schiefer MD; Colin L.W. Driscoll MD; Bruce E. Pollock MD; Michael J. Link MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2012 Annual Meeting

    Introduction: Modern software and high resolution imaging modalities have improved radiosurgical treatment for vestibular schwannoma (VS). Predictors of hearing loss following treatment are imperative for patient counseling and disease management.

    Methods: A prospectively maintained database of patients with serviceable hearing [American Academy of Otolaryngology-Head and Neck Surgery (AAOHNS) class A or B] who underwent gamma knife radiosurgery (GKS) for VS between 2007 and 2011 was reviewed. The study was limited to subjects treated using the Perfexion Gamma Plan system who underwent high-resolution computed tomography (CT) for treatment planning. Clinical features including patient and tumor characteristics, pre- and post-operative audiometric data, and radiosurgical planning parameters including mean and max doses to 3D volumes of the cochlea were analyzed. Univariate and multivariate associations were evaluated using logistic regression models.

    Results: Fifty-nine patients met study criteria and were included. Mean and median post-operative audiometric follow-up was 20 and 14 months respectively. Sixty-four percent of all subjects and 77% of AAOHNS class A patients maintained serviceable hearing during the follow-up period. Tumor control was achieved in 97% of patients. Patients with a pre-operative speech discrimination score (SDS) <70% were 11.1 times more likely to develop non-serviceable hearing (AAOHNS class C or D)(OR 0.09; p=0.031) and 12.5 times more likely to have >10% drop in SDS (OR 0.08; p=0.037) following GKS. Radiosurgical dose analysis revealed that patients with a tumor margin dose >13Gy were 7.0 times more likely to develop non-serviceable hearing (OR 6.95; p=0.005); each 1Gy increase in cochlear max was associated with a 32% increased odds of developing non-serviceable hearing (OR 1.32; p=0.008).

    Conclusions: Excellent pretreatment hearing and tumor margin dose were jointly associated with hearing preservation following GKS. While cochlear dose may play a role in hearing preservation, hearing loss following GKS is likely multifactorial and complete tumor treatment is recommended for optimal tumor control.

    Patient Care: Our data suggests that radiosurgical treatment plans for vestibular schwannoma should encompass the whole tumor for the best chance at tumor control as hearing loss following GKS appears to be a multifactorial process.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Understand the use of 3-dimensional cochlear volumes using high resolution CT to obtain mean and max cochlear doses and how this relates to traditional MRI-based point-dose calculations. 2) Understand how cochlear dose relates to loss of serviceable hearing following GKS for VS. 3) Understand how various clincal and radiosurgical parameters play a role in hearing loss following GKS for improved patient counseling.

    References: 1) Kano H, Kondziolka D, Khan A, et al. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg. 2009;111(4):863-873. 2) Massager N, Nissim O, Delbrouck C, et al. Role of intracanalicular volumetric and dosimetric parameters on hearing preservation after vestibular schwannoma radiosurgery. Int J Radiat Oncol Biol Phys. 2006;64(5):1331-1340. 3) Massager N, Nissim O, Delbrouck C, et al. Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome. J Neurosurg. 2007;107(4):733-739. 4) Pollock BE, Driscoll C, Foote CL, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery. 2006;59(1):77-85. 5) Tamura M, Carron R, Yomo S, et al. Hearing preservation after gamma knife radiosurgery for vestibular schwannomas presenting with high-level hearing. Neurosurgery. 2009 Feb;64(2):289-96; discussion 296. 6) Brown M, Ruckenstein M, Bigelow D, et al. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage. Neurosurgery. 2011 Sep;69(3):605-13; discussion 613-4 7) Wackym PA, Runge-Samuelson CL, Nash JJ, et al. Gamma knife surgery of vestibular schwannomas: volumetric dosimetry correlations to hearing loss suggest stria vascularis devascularization as the mechanism of early hearing loss. Otol Neurotol. 2010 Dec;31(9):1480-7.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy